James R. Tobin - Mar 4, 2022 Form 3 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for James R. Tobin
Stock symbol
LYRA
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
3
Date filed
3/8/2022, 03:24 PM
Previous filing
Jan 31, 2022
Next filing
Mar 10, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.